Robert Michael
Vermogen: 39 M $ op 31-05-2026
Vermogen: 39 M $ op 31-05-2026
Robert A. Michael is Chief Financial Officer & Executive Vice President bij AbbVie, Inc. en Chief Executive Officer bij Fremont Holding LLC, Chief Executive Officer bij Tobira Therapeutics, Inc. en President & Director bij Allergan Plc (die alle dochterondernemingen zijn van AbbVie, Inc.). De heer Michael zit ook in de Raad van Bestuur van AbbVie Biotherapeutics Ltd. Voorheen bekleedde de heer Michael de functie van Division Controller-Nutrition Supply Chain bij Abbott Laboratories. Hij behaalde een MBA aan de Anderson School of Management.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
ABBVIE, INC. 0,01% | 06-03-2026 | 178.737 ( 0,01% ) | 39 M $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| ABBVIE INC. | Algemeen Directeur | 01-07-2024 |
| ALLERGAN PLC | President | 08-05-2020 |
| TOBIRA THERAPEUTICS INC | Algemeen Directeur | - |
AbbVie Biotherapeutics Ltd.
AbbVie Biotherapeutics Ltd. Financial ConglomeratesFinance Functions as an investment holding company | Directeur/Bestuurslid | 01-04-2019 |
Fremont Holding LLC
Fremont Holding LLC Pharmaceuticals: MajorHealth Technology Fremont Holding LLC engages in provision of pharmaceutical services. The company is headquartered in North Chicago, IL. | Algemeen Directeur | - |
AbbVie Ltd. (United Kingdom)
AbbVie Ltd. (United Kingdom) Miscellaneous Commercial ServicesCommercial Services Develops advanced therapies through research and innovation | President | 01-01-2022 |
| Bedrijven | Functie | Einde |
|---|---|---|
| ABBOTT LABORATORIES | Corporate Officer/Principal | 01-08-2012 |
Allergan GI Corp.
Allergan GI Corp. BiotechnologyHealth Technology Develops peptide therapeutics for the treatment of gastrointestinal diseases | President | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 10 |
|---|---|
Abbott Laboratories
Abbott Laboratories Medical SpecialtiesHealth Technology Develops and manufactures medical devices, diagnostic systems, pharmaceuticals & nutritional products | Health Technology |
AbbVie, Inc.
AbbVie, Inc. Pharmaceuticals: MajorHealth Technology Engages in the research and development, manufacturing, commercialization & sale of immunology medicines and therapies | Health Technology |
Allergan Ltd. (Ireland)
Allergan Ltd. (Ireland) Pharmaceuticals: MajorHealth Technology Develops, manufactures and commercializes pharmaceuticals, devices, biological, surgical & regenerative medicine products | Health Technology |
Allergan GI Corp.
Allergan GI Corp. BiotechnologyHealth Technology Develops peptide therapeutics for the treatment of gastrointestinal diseases | Health Technology |
Fremont Holding LLC
Fremont Holding LLC Pharmaceuticals: MajorHealth Technology Fremont Holding LLC engages in provision of pharmaceutical services. The company is headquartered in North Chicago, IL. | Health Technology |
AbbVie Ltd. (United Kingdom)
AbbVie Ltd. (United Kingdom) Miscellaneous Commercial ServicesCommercial Services Develops advanced therapies through research and innovation | Commercial Services |
Kelley School of Business
Kelley School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
UCLA Anderson School of Management
UCLA Anderson School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tobira Therapeutics, Inc.
Tobira Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops and commercializes therapeutics to treat liver , inflammation, fibrosis & HIV diseases | Health Technology |
AbbVie Biotherapeutics Ltd.
AbbVie Biotherapeutics Ltd. Financial ConglomeratesFinance Functions as an investment holding company | Finance |
Kies jouw editie
Alle financiële informatie op nationaal niveau